Pentagon makes Pfizer vaccine mandatory after FDA approval- memo
Reuters
Published Aug 25, 2021 09:39AM ET
Updated Aug 25, 2021 10:55AM ET
WASHINGTON (Reuters) -The Pentagon on Wednesday ordered all active-duty service members to be vaccinated with the Pfizer/BioNTech COVID-19 vaccine days after the Food and Drug Administration granted it full approval.
In a memo seen by Reuters, the Pentagon ordered the military to start the process immediately but did not put a specific timeline on when it should be completed.
Earlier in the week it had said that such a move would be coming.
The U.S. military has said that around half the U.S. armed forces are already fully vaccinated, a number that climbs significantly when counting only active-duty troops and excluding National Guard and Reserve members.
Vaccination rates are highest in the Navy, which suffered from a high-profile outbreak last year aboard an aircraft carrier.
Because U.S. service members are generally younger and fitter, relatively few of them have died as a result of COVID-19.
The Pfizer (NYSE:PFE) shot became the first COVID-19 vaccine to be fully approved by the FDA.
The FDA, which gave the two-dose vaccine emergency-use authorization in December, provided its full approval for use in people age 16 and older based on updated data from the companies' clinical trial and manufacturing review.
There is entrenched vaccine skepticism among some Americans, particularly conservatives. COVID-19 cases, driven by the highly infectious Delta variant, have surged in parts of the United States with lower vaccination levels.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.